Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [5205]

Researchers discover why one type of chemotherapy works best in bladder cancer

Researchers discover why one type of chemotherapy works best in bladder cancer

ASCO GU 2024: Study shows positive results for patients with muscle-invasive urothelial carcinoma

ASCO GU 2024: Study shows positive results for patients with muscle-invasive urothelial carcinoma

New study assesses long term risk of invasive breast cancer after pre-invasive disease

New study assesses long term risk of invasive breast cancer after pre-invasive disease

Researchers develop a light-responsive novel drug delivery system against skin cancer

Researchers develop a light-responsive novel drug delivery system against skin cancer

Primary care physicians and urologists work together to provide optimal care for men with low-risk prostate cancer

Primary care physicians and urologists work together to provide optimal care for men with low-risk prostate cancer

FDA approves erdafitinib for locally advanced or metastatic urothelial carcinoma

FDA approves erdafitinib for locally advanced or metastatic urothelial carcinoma

ASCO GI 2024: New immunotherapy combinations for patients with oesophageal cancer

ASCO GI 2024: New immunotherapy combinations for patients with oesophageal cancer

ASCO GI 2024: New study adds to ambiguity of role of post-operative ctDNA to guide treatment in patients with low-risk, stage IIA colon cancer

ASCO GI 2024: New study adds to ambiguity of role of post-operative ctDNA to guide treatment in patients with low...

CD19-targeted CAR NK cell therapy achieves promising one-year results in patients with B-cell malignancies

CD19-targeted CAR NK cell therapy achieves promising one-year results in patients with B-cell malignancies

AI harnesses tumour genetics to predict treatment response

AI harnesses tumour genetics to predict treatment response

More from ecancer